Inventor · disambiguated record
Erkki A. O. Nissinen
Also filed as: NISSINEN ERKKI · NISSINEN ERKKI A O
13 granted patents·455 citations·filing 1987–2001
93Inventor score
Top patents by PatentIndex Score
13 records- 0196US5446194APharmacologically active catechol derivativesORION YHTYMAE OY·Filed 1993·Granted Aug 29, 1995·108 cites·4 claims
- 0296US4963590APharmacologically active compounds, methods for the preparation thereof and compositions containing the sameORION YHTYMAE OY·Filed 1987·Granted Oct 16, 1990·156 cites·14 claims
- 0395US5283352APharmacologically active compounds, methods for the preparation thereof and compositions containing the sameORION YHTYMAE OY·Filed 1992·Granted Feb 1, 1994·60 cites·3 claims
- 0482US5112861AMethod of treating parkinson's disease using pentanedione derivativesORION YHTYMAE OY·Filed 1990·Granted May 12, 1992·48 cites·16 claims
- 0574US5292771ASubstituted β-diketones and their useORION YHTYMAE OY·Filed 1992·Granted Mar 8, 1994·12 cites·12 claims
- 0671US5185370ASubstituted β-diketones and their useORION YHTYMAE OY·Filed 1991·Granted Feb 9, 1993·10 cites·9 claims
- 0763US5614541APharmacologically active catechol derivativesORION YHTYMAE OY·Filed 1994·Granted Mar 25, 1997·13 cites·15 claims
- 0860US5362733APharmacologically active catechol derivativesORION YHTYMAE OY·Filed 1991·Granted Nov 8, 1994·11 cites·13 claims
- 0959US6121303APharmacologically active catechol derivativesORION YHTYMAE OY·Filed 1999·Granted Sep 19, 2000·7 cites·11 claims
- 1052US5889037APharmacologically active catechol derivativesORION YHTYMAE OY·Filed 1995·Granted Mar 30, 1999·8 cites·2 claims
- 1152US5489614ACatechol derivatives, their physiologically acceptable salts, esters and useORION YHTYMAE OY·Filed 1995·Granted Feb 6, 1996·14 cites·2 claims
- 1241US5288750ASubstituted β-diketonesORION YHTYMAE OY·Filed 1989·Granted Feb 22, 1994·8 cites·10 claims
- 1340US6878702B2Anti-inflammatory agentsORION CORP·Filed 2001·Granted Apr 12, 2005·0 cites·5 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →